- SENIOR ASSOCIATE DEAN FOR CLINICAL AFFAIRS Mount Sinai Beth Israel
- PROFESSOR Urology
American Board of Urology
MD, Temple University School of Medicine
New York Presbyterian Medical Center / Columbia
New York Presbyterian Medical Center / Columbia
Harris M. Nagler, M.D., FACS is a Professor of Urology at the Icahn School of Medicine at Mount Sinai. He previously served as President of the Beth Israel Medical Center, Chair of the Sol and Margaret Berger Department of Urology Physician-in-Chief of Mount Sinai Beth Israel, Chief of Graduate Medical Education/Academic Affairs at the Beth Israel, Program Director of the urology residency training program and Chief Medical Officer. Dr Nagler’s clinical practice focuses on male infertility, erectile dysfunction and general urology.
Dr Nagler is an Alpha Omega Alpha graduate of Temple University School of Medicine which recently honored him by placing him in the Hall of Fame. He completed his urological training and a fellowship in reproductive medicine and surgery at Columbia Presbyterian Medical Center where he was on the faculty until he moved to Beth Israel to Chair the Department of Urology.
He is the recipient of many national and regional honors. He has been recognized numerous times in New York Magazine’s Best Doctors listing. Additionally, he has been listed in the Best Doctors in the United States and has been recognized in Becker’s as one of the 130 nonprofit Hospital leaders to know, as well as one of the 300 Hospital and Health Systems Leaders to know.
He has received many honors as a clinician and researcher. In 1986, Columbia University honored him when he received the prestigious Drs. Harold and Goldman Lampert Award for Excellence in Clinical Research. He has received the ACMI Urology Prize of the American Fertility Society, First Prize for Clinical Research in the American Urological Association Prize Essay Contest, the American Fertility Society Urology Prize, the John K. Lattimer Award of the Kidney and Urology Foundation of America. In 2007, he received the received the Russell Lavengood Award for Distinguished service from the New York Section of the American Urological Association in 2007.
Dr Nagler is a member or many prestigious organizations including the Alpha Omega Alpha medical Honor Society. In addition to membership in these societies he was the President of the Society for the Study of Male Reproduction of the American Urological Association and President of the Society of Reproductive Surgeons of the American Society of Reproductive Medicine.
He is or has been on the editorial boards of the Journal of Urology, Fertility and Sterility, Nature Urology, Assisted Reproductive Reviews, Journal of Andrology, Molecular Andrology, Gynecologic and Obstetric Investigation, the Brazilian Journal of Urology and the Asian Journal of Andrology. He has published extensively in peer reviewed journals on many urological topics and has co-edited four books focusing on the treatment of male infertility.
He has been on the Board of many organizations including the Society for the Study of Male Reproduction and the New York Section of the American Urological Association. He was formerly the treasurer of the New York Section of the AUA, and served as the President of the New York Section of Urology.
He served as the Chair of both the Ethics and the Judicial Committee of the AUA and the By-Laws Committees of the AUA.
He has been recognized by the American Urological Association with the Distinguished Service Award and the Union Square Partnerships award for Community Service.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Nagler did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.